BCBS Arkansas Medical Policy Updates – May 2019

Click here to view the Blue Cross Blue Shield Arkansas Medical Policy Updates »

May 2019 BCBS Arkansas Medical Policy Updates:

• Accelerated Breast Irradiation after Breast-Conserving Surgery for Early Stage Breast Cancer and Breast Brachytherapy as Boost with Whole-Breast Irradiation
• Andexxa®(recombinant coagulation factor Xa, inactivated-zhzo injection)
• Automated Visual Evoked Potentials for Routine Vision Screening in Pediatrics
• Balloon Ostial Dilation for Treatment of Chronic Rhinosinusitis
• Bioimpedance Devices for Detection and Management of Lymphedema
• Blepharoplasty and Repair of Brow Ptosis
• Blue Cross and BCN utilization management medical drug list
• BMT – Hematopoietic Cell Transplantation for Primary Amyloidosis
• BMT- Hematopoietic Cell Transplantation (HCT) for CNS Embryonal Tumors and Ependymoma
• Bone Marrow – Hematopoietic Cell Transplant for Waldenström’s Macroglobulinemia
• Bone Marrow Transplant – Hematopoietic Cell Transplantation for Epithelial Ovarian Cancer
• Bone Marrow/Hematopoietic Cell Transplantation for Miscellaneous Solid Tumors in Adults
• Brachytherapy for Clinically Localized Prostate Cancer Using Permanently Implanted Seeds
• Cerebrospinal Fluid and Urinary Biomarkers of Alzheimer’s Disease
• Chelation Therapy, Including Off-Label Uses
• Chronic Intermittent Intravenous Insulin Therapy (CIIIT)
• Cognitive Rehabilitation
• Coherence Tomography (OCT) of the Middle Ear
• Composite Tissue Allotransplantation
• Computer-Aided Evaluation as an Adjunct to Magnetic Resonance Imaging of the Breast
• Computerized 2-lead Resting Electrocardiogram Analysis for the Diagnosis of Coronary Artery Disease
• Continuous Passive Motion Machine (CPM)
• Contrast-Enhanced Computed Tomography Angiography (CTA, CCTA, MDCT, MSCT) of the Heart and/or Coronary Arteries
• Corneal Liquid Bandage Lens for Corneal Epithelial Defects/Scleral Lenses
• Cosmetic and Reconstructive Surgery
• CPT Category III Codes-Noncovered Services
• Cryosurgical Ablation of Miscellaneous Solid Tumors Other Than Liver, Prostate, or Dermatologic Tumors
• CT (Computed Tomography) Perfusion Imaging of the Brain
• Defecography
• Drug Testing of Urine, Oral Fluids and Hair
• Echosclerotherapy for the Treatment of Varicose Veins
• Enteral Nutrition
• Extra-Aortic Counter-Pulsation Ventricular Assist System
• Extracranial Carotid Artery Stenting
• Facet Joint Denervation
• Fecal Incontinence—Investigational Treatments
• Femtosecond Laser in Keratoplasty
• Fetal Surgery for Prenatally Diagnosed Malformations
• Fusilev®(levoleucovorin)
• Genetic Testing – Analysis of MGMT Promoter Methylation in Malignant Gliomas
• Genetic Testing and Counseling
• Genetic Testing for Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D)
• Genetic Testing for Cardiac Ion Channelopathies
• Genetic Testing for Cytochrome P450 Polymorphisms
• Genetic Testing for HLA-B 1502 before Carbamazepine Therapy
• Genetic Testing for Inherited Hypertrophic Cardiomyopathy
• Genetic Testing for Marfan Syndrome, Thoracic Aortic Aneurysms and Dissections, and Related Disorders
• Genetic Testing for Noonan Spectrum Disorder
• Genetic Testing for Pharmacogenetic Testing for Pain Management
• Genetic Testing of CADASIL Syndrome
• Genetic Testing-Gene Expression Profiling for Uveal Melanoma
• Immune Cell Function Assay
• Intravitreal Corticosteroid Implants
• Khapzory™(levoleucovorin)
• Libtayo®(cemiplimab-rwlc)
• Lumoxiti ™(moxetumomab pasudotox-tdfk)
• Obstructive Sleep Apnea and Snoring – Surgical Treatment
• Oral Surgery
• Percutaneous Tibial Nerve Stimulation
• Percutaneous Transluminal Angioplasty (PTA) for the Treatment of Cerebral Vasospasm
• Peripheral Subcutaneous Field Stimulation
• Photodynamic Therapy for Dermatologic Applications
• Positional Magnetic Resonance Imaging
• Postsurgical Home Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis
• Proteomic Testing for Targeted Therapy in Non-Small-Cell Lung Cancer (NSCLC), e.g., VeriStrat®
• Radioembolization for Primary and Metastatic Tumors of the Liver
• Radiofrequency Ablation of Miscellaneous Solid Tumors, Excluding Liver Tumors
• Recombinant and Autologous Platelet-Derived Growth Factors as a Treatment of Wound Healing and Other Non-Orthopedic Conditions
• Screening for Lung Cancer Using Computed Tomography Scanning or Chest Radiographs
• Serum Biomarker Human Epididymis Protein 4 (HE4)
• SpravatoTM(esketamine)
• Stand-Alone Ultrasound for Routine Breast Cancer Screening
• Suprachoroidal Delivery of Pharmacologic Agent
• Telemedicine
• Telemedicine
• Telemedicine
• Tumor Treating Fields Therapy
• Ultrafiltration in Decompensated Heart Failure
• Ultrasonographic Measurement of Carotid Intima-Medial Thickness as an Assessment of Subclinical Atherosclerosis
• Virtual Colonoscopy/CT Colonography

Click here to view the Blue Cross Blue Shield Arkansas Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.